Status:
UNKNOWN
Efferocytosis and Genomic Polymorphism in Autoimmune Diseases
Lead Sponsor:
National Taiwan University Hospital
Conditions:
SLE
Rheumatoid Arthritis
Eligibility:
All Genders
20+ years
Brief Summary
Over the past few years, growing evidences revealed that clearance of apoptotic cells by phagocytosis can result in powerful anti-inflammatory and immunosuppressive effects. In vivo, apoptotic cells a...
Detailed Description
Over the past few years, there were growing evidences that clearance of apoptotic cells by phagocytosis can result in powerful anti-inflammatory and immunosuppressive effects. The defective clearance ...
Eligibility Criteria
Inclusion
- SLE, RA, healthy
Exclusion
- nil
Key Trial Info
Start Date :
January 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 1 2012
Estimated Enrollment :
450 Patients enrolled
Trial Details
Trial ID
NCT00364728
Start Date
January 1 2006
End Date
July 1 2012
Last Update
May 21 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chung-Yi Hu
Taipei, Taiwan, Taiwan, 100